Ultrasound-guided 8-Gauge vacuum-assisted excision for selected B3 breast lesions: a preliminary experience.

Giovanna Panzironi, Giuliana Moffa, Francesca Galati, Federica Pediconi

Abstract read

In one paragraph

Article in La Radiologia medica, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it

0cells of the map it votes in

8citing papers in PubMed

1.2field-weighted citation impact, top 21% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

Budget Impact Analysis of Vacuum-Assisted Excision Versus Surgical Excision for the Assessment of Breast Lesions of Uncertain Malignant Potential in Italy.PharmacoEconomics - open · 2026
Article
Value of ultrasound-guided vacuum-assisted excision in the treatment of non-malignant breast nodules diagnosed as BI-RADS 4A or higher by ultrasound.Gland surgery · 2026
Article
Peritoneal Carcinosis: What the Radiologist Needs to Know.Diagnostics (Basel, Switzerland) · 2023
Review
Percutaneous vacuum-assisted excision (VAE) of breast lesions of uncertain malignant potential (B3 lesions): a preliminary single-centre Italian experience.La Radiologia medica · 2023
Article
Recent Advances in Ultrasound Breast Imaging: From Industry to Clinical Practice.Diagnostics (Basel, Switzerland) · 2023
Review
Structured reporting of x-ray mammography in the first diagnosis of breast cancer: a Delphi consensus proposal.La Radiologia medica · 2022
Article
Risk factors for hematoma formation after ultrasound-guided vacuum-assisted excision of breast fibroadenoma: An analysis based on ultrasound features.Science progress
Article
A Single Centre Feasibility Study of Vacuum Assisted Breast Biopsy Excision as a Non-Surgical Alternative for Selected Women With Borderline Breast Lesions.ANZ journal of surgery
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Giovanna PanzironiDepartment of Radiological, Oncological and Pathological Sciences, Sapienza - University of Rome, Rome, Italy.ORCID http://orcid.org/0000-0001-7763-2362

Giuliana MoffaDepartment of Radiological, Oncological and Pathological Sciences, Sapienza - University of Rome, Rome, Italy. moffa.giuliana@gmail.com.ORCID http://orcid.org/0000-0002-6595-1611

Francesca GalatiDepartment of Radiological, Oncological and Pathological Sciences, Sapienza - University of Rome, Rome, Italy.ORCID http://orcid.org/0000-0003-2103-2856

Federica PediconiDepartment of Radiological, Oncological and Pathological Sciences, Sapienza - University of Rome, Rome, Italy.ORCID http://orcid.org/0000-0002-1432-2137

Sapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeNowadays, surgical excision is no longer justified for all B3 lesions and a minimally-invasive therapeutic treatment has been encouraged. The aim of this study was to evaluate the feasibility and the therapeutic efficacy of ultrasound-guided vacuum-assisted excision (US-VAE) for the treatment of selected breast lesions of uncertain malignant potential (B3). MATERIAL AND

methodsFrom July 2018 to December 2019, 11/48 breast lesions classified as B3 after ultrasound-guided core needle biopsy were treated with US-VAE in our Institution. Inclusion criteria were: B3 nodules ultrasonographically detectable for which VAE is recommended by international guidelines

resultsComplete excision was achieved in 81.8% of US-VAE. No lesions were upgraded to carcinoma and no patients had to undergo surgery. No complications occurred during or after US-VAE. All patients were satisfied with the procedure and the cosmetic result (100%). US-VAE cost approximately 422 Euros per procedure.

conclusionUS-VAE has proven to be an optimal tool for the therapeutic excision of selected B3 lesions, with high success rate, good patient compliance and considerable money savings compared to surgery. This technique has the potential to reduce unnecessary surgery and healthcare costs.

Indexed as

AdultAgedAged, 80 and overBreastBreast NeoplasmsFemaleHumansMiddle AgedTreatment OutcomeUltrasonography, InterventionalVacuumB3 lesionsBreast lesions of uncertain malignant potentialTreatment of breast lesionsUltrasoundVacuum-assisted excision

Identifiers

PMID34800217

DOI10.1007/s11547-021-01429-6

OpenAlexW3213303709

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.